OPKO Health, Inc. Goodwill
OPKO Health, Inc. (OPK) had Goodwill of $481.51 million as of 2026-06-30, per its 10-Q/A filed 2026-08-28.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:Goodwill · last filed 2026-08-28
- 2026-06-30: Goodwill $481.51M.
- 2026-03-31: Goodwill $482.27M.
- 2025-12-31: Goodwill $484.29M.
- 2025-09-30: Goodwill $484.03M.
| Period end | Goodwill | Goodwill as first filed |
|---|---|---|
| 2026-06-30 | $481.51M 10-Q/A · filed 2026-08-28 | |
| 2026-03-31 | $482.27M 10-Q/A · filed 2026-08-28 | |
| 2025-12-31 | $484.29M 10-Q/A · filed 2026-08-28 | |
| 2025-09-30 | $484.03M 10-Q · filed 2025-10-29 | |
| 2025-06-30 | $484.19M 10-Q · filed 2025-07-31 | |
| 2025-03-31 | $476.67M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $529.25M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $535.87M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $530.11M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $530.62M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $598.26M 10-K · filed 2025-03-03 | |
| 2023-09-30 | $594.46M 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $597.38M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $597.38M 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $595.85M 10-K · filed 2024-03-01 | |
| 2022-09-30 | $573.50M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $578.85M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $519.05M 10-Q · filed 2022-05-09 | |
| 2022-01-01 | $633.87M 10-Q · filed 2023-05-03 | $710.41M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $520.60M 10-K · filed 2023-02-27 | |
| 2021-09-30 | $674.57M 10-Q · filed 2021-10-28 | |
| 2021-06-30 | $677.36M 10-Q · filed 2021-07-29 | |
| 2021-03-31 | $676.16M 10-Q · filed 2021-04-28 | |
| 2021-01-01 | $718.63M 10-K · filed 2023-02-27 | |
| 2020-12-31 | $680.60M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $675.79M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $671.60M 10-Q · filed 2020-07-31 | |
| 2020-03-31 | $669.58M 10-Q · filed 2020-05-06 | |
| 2020-01-01 | $709.96M 10-K · filed 2022-03-01 | |
| 2019-12-31 | $671.94M 10-K · filed 2021-02-18 | |
| 2019-09-30 | $695.80M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $699.84M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $698.52M 10-Q · filed 2019-05-08 | |
| 2019-01-01 | $711.99M 10-K · filed 2021-02-18 | |
| 2018-12-31 | $700.19M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $713.63M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $714.23M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $719.89M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $717.10M 10-K · filed 2020-03-02 | |
| 2017-09-30 | $715.57M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $712.08M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $705.99M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $704.60M 10-K · filed 2019-03-01 | |
| 2016-09-30 | $700.53M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $691.06M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $746.96M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $743.35M 8-K · filed 2019-01-29 | |
| 2015-09-30 | $761.23M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $289.61M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $223.22M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $224.29M 10-K · filed 2017-03-01 | |
| 2014-09-30 | $224.77M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $226.00M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $226.06M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $226.37M 10-K · filed 2016-02-29 | |
| 2013-09-30 | $222.34M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $82.09M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $82.71M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $80.45M 10-K · filed 2015-02-27 | |
| 2012-09-30 | $49.74M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $40.99M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $40.32M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $39.81M 10-K · filed 2014-03-03 | |
| 2011-09-30 | $6.23M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $6.85M 10-Q · filed 2011-08-08 | |
| 2010-12-31 | $5.86M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |